Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Symanowski

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Clinical Pharmacology and Therapeutics|September 25, 2019
Evaluation of CYP2C19 Genotype-Guided Voriconazole Prophylaxis After Allogeneic Hematopoietic Cell TransplantJai N Patel, Issam S Hamadeh, Myra Robinson, et al.
Gynecologic Oncology|February 7, 2018
HOXA4/HOXB3 gene expression signature as a biomarker of recurrence in patients with high-grade serous ovarian cancer following primary cytoreductive surgery and first-line adjuvant chemotherapyKatherine R Miller, Jai N Patel, Qing Zhang, et al.
Urologic Oncology|June 6, 2022
Identification of potential biomarkers and novel therapeutic targets through genomic analysis of small cell bladder carcinoma and associated clinical outcomesEarle F Burgess, J Alexa Sanders, Chad Livasy, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 1, 2019
Effect of CYP3A4, CYP3A5, and ABCB1 Polymorphisms on Intravenous Tacrolimus Exposure and Adverse Events in Adult Allogeneic Stem Cell Transplant PatientsIssam S Hamadeh, Qing Zhang, Nury Steuerwald, et al.
Journal of Clinical Apheresis|March 12, 2021
Cost saving, patient centered algorithm for progenitor cell mobilization for autologous hematopoietic cell transplantationSrinivasa Reddy Sanikommu, Emily S Reese, Jiaxian He, et al.
Annals of Hematology|April 25, 2024
Hematocrit control and thrombotic risk in patients with polycythemia vera treated with ruxolitinib in clinical practiceAleksander Chojecki, Danielle Boselli, Allison Dortilus, et al.
Leukemia Research|June 26, 2022
Outcomes and hospitalization patterns of patients with acute myelogenous leukemia treated with frontline CPX-351 or HMA/venetoclaxAleksander L Chojecki, Justin Arnall, Danielle Boselli, et al.
Blood Advances|February 20, 2026
Belantamab mafodotin, carfilzomib, lenalidomide, and dexamethasone for relapsed or refractory multiple myelomaShebli Atrash, James Symanowski, Myra Robinson, et al.
Annals of Surgery|November 12, 2025
A Randomized, Single-Center, Superiority Trial of Radioactive Seed Localization Versus Wire Localization for Malignant Breast DiseaseLejla Hadzikadic-Gusic, Jessica Bilz, Danielle Boselli, et al.
JCO Precision Oncology|June 27, 2024
Real-World Impact of an In-House Dihydropyrimidine Dehydrogenase (<i>DPYD</i>) Genotype Test on Fluoropyrimidine Dosing, Toxicities, and Hospitalizations at a Multisite Cancer CenterD Grace Nguyen, Sarah A Morris, Alicia Hamilton, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Clinical Pharmacology and Therapeutics|September 25, 2019
Evaluation of CYP2C19 Genotype-Guided Voriconazole Prophylaxis After Allogeneic Hematopoietic Cell TransplantJai N Patel, Issam S Hamadeh, Myra Robinson, et al.
Gynecologic Oncology|February 7, 2018
HOXA4/HOXB3 gene expression signature as a biomarker of recurrence in patients with high-grade serous ovarian cancer following primary cytoreductive surgery and first-line adjuvant chemotherapyKatherine R Miller, Jai N Patel, Qing Zhang, et al.
Urologic Oncology|June 6, 2022
Identification of potential biomarkers and novel therapeutic targets through genomic analysis of small cell bladder carcinoma and associated clinical outcomesEarle F Burgess, J Alexa Sanders, Chad Livasy, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 1, 2019
Effect of CYP3A4, CYP3A5, and ABCB1 Polymorphisms on Intravenous Tacrolimus Exposure and Adverse Events in Adult Allogeneic Stem Cell Transplant PatientsIssam S Hamadeh, Qing Zhang, Nury Steuerwald, et al.
Journal of Clinical Apheresis|March 12, 2021
Cost saving, patient centered algorithm for progenitor cell mobilization for autologous hematopoietic cell transplantationSrinivasa Reddy Sanikommu, Emily S Reese, Jiaxian He, et al.
Annals of Hematology|April 25, 2024
Hematocrit control and thrombotic risk in patients with polycythemia vera treated with ruxolitinib in clinical practiceAleksander Chojecki, Danielle Boselli, Allison Dortilus, et al.
Leukemia Research|June 26, 2022
Outcomes and hospitalization patterns of patients with acute myelogenous leukemia treated with frontline CPX-351 or HMA/venetoclaxAleksander L Chojecki, Justin Arnall, Danielle Boselli, et al.
Blood Advances|February 20, 2026
Belantamab mafodotin, carfilzomib, lenalidomide, and dexamethasone for relapsed or refractory multiple myelomaShebli Atrash, James Symanowski, Myra Robinson, et al.
Annals of Surgery|November 12, 2025
A Randomized, Single-Center, Superiority Trial of Radioactive Seed Localization Versus Wire Localization for Malignant Breast DiseaseLejla Hadzikadic-Gusic, Jessica Bilz, Danielle Boselli, et al.
JCO Precision Oncology|June 27, 2024
Real-World Impact of an In-House Dihydropyrimidine Dehydrogenase (<i>DPYD</i>) Genotype Test on Fluoropyrimidine Dosing, Toxicities, and Hospitalizations at a Multisite Cancer CenterD Grace Nguyen, Sarah A Morris, Alicia Hamilton, et al.
Pageof 4